“Convergence is a very important word to the Harmonics Group. But we realized early on that change happens when we look beyond just economic success. Change is all about convergence. It is about convergence of technologies surrounding the atom, the bit, and the cell. The foundational Quantum Dot technology can be used to measure multitudes of other biomarkers in the human body to improve the way we see and manage health. But that one-dimensional change can be amplified if we used the quantitative results along with data science to help create mathematical models that we can apply to population studies to help manage infectious diseases, long-term effects of an infectious agent like Covid19 on society, and a host of other predictive models. Applied to advances in drug delivery systems, the measurement of biomarkers accelerates drug development, accurately measures increases in bioavailability of beneficial pharmaceutical active ingredients and on the other side of the spectrum, reductions in side effects. These are convergences of technologies surrounding the atom, the bit, and the cell that we are working on to maximize positive change.
But change is more than just the convergence of technologies. Change is about the convergence of people from different sectors working together to make a better place. Our common place. Working together to make our place better. Change happens when we set aside beliefs, race, culture, geographical divides, and converge towards a common goal, not for self-enrichment, but to enrich everybody else’s journey through life. We’ve developed breakthrough technologies in biomarker quantification using Quantum Dot Technology in GeneHarmonics Inc. We are in the last stages of completing companion Data Platforms in BitHarmonics Inc. to help create predictive models for a healthier society in an information company that we are incubating. And we are using the fusion of both our quantum dot and data technologies to help in the development of better medications in a drug delivery company that is also under incubation.
We are working with global companies, universities, non-profits organizations, and experts in their respective fields to make a difference in private and public health. It’s a big task but…we have cutting-edge technologies. We have the right partners. We have the right team.”